This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Willette, R. N. Articles by Sulpizio, A. C. Search for Related Content PubMed PubMed Citation Articles by Willette, R. N. Articles by Sulpizio, A. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Transient Ischemic Attack

Stroke, Vol 25, 2450-2455, Copyright © 1994 by American Heart Association

ARTICLES

Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm

RN Willette, H Zhang, MP Mitchell, CF Sauermelch, EH Ohlstein and AC Sulpizio
SmithKline Beecham Pharmaceuticals, Department of Cardiovascular Pharmacology, King of Prussia, Pa 19406.

BACKGROUND AND PURPOSE: (+/-)-SB 209670, a potent nonpeptide endothelin (ET) receptor antagonist, was used to investigate the potential role of ET in cerebral vasospasm associated with subarachnoid hemorrhage. METHODS: The effects of (+/-)-SB 209670 were evaluated in isolated segments of canine posterior cerebral arteries in vitro, vascular smooth muscle cells in culture, and in the canine two-hemorrhage model of delayed cerebral vasospasm in vivo. RESULTS: In the canine basilar and anterior spinal arteries, (+/-)-SB 209670 caused a dose-related inhibition of contractile responses mediated by ET (KB = 4.6 nmol/L and apparent KB = 2.7 nmol/L, respectively). The effects of (+/-)-SB 209670 were mediated by inhibition of ETA receptors since the ETB selective agonist sarafotoxin 6c did not contract these posterior cerebral vessels. (+/-)-SB 209670 also produced a concentration-dependent inhibition (IC50 = 1 nmol/L) of the mitogenic response induced by ET-1 in vascular smooth muscle cell culture. In the canine model of delayed cerebral vasospasm, animals received intracisternal vehicle (saline) or (+/-)-SB 209670 (360 +/- 10 micrograms/d) via osmotic minipump for 7 days. On day 7, the cross-sectional areas in the (+/-)-SB 209670 group were significantly greater than those in the vehicle group in both the basilar artery (68% versus 27%) and anterior spinal artery (78% versus 38%). No differences in blood pressure or heart rate were noted in the two groups, and the vasospasm in the vehicle group did not differ from that of historic controls in this model. CONCLUSIONS: The results suggest that ET plays a significant role in the development of delayed cerebral vasospasm via an interaction with ETA receptors. Furthermore, ETA receptor antagonists may represent a novel therapeutic approach to the treatment of subarachnoid hemorrhage.

This article has been cited by other articles:

				M. Zuccarello, R. Boccaletti, A. Romano, R. M. Rapoport, and J. P. Muizelaar Endothelin B Receptor Antagonists Attenuate Subarachnoid Hemorrhage–Induced Cerebral Vasospasm • Editorial Comment Stroke, September 1, 1998; 29(9): 1924 - 1929. [Abstract] [Full Text] [PDF]

				F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF]

				R. N. Willette, E. H. Ohlstein, M. P. Mitchell, C. F. Sauermelch, G. R. Beck, M. A. Luttmann, and D. W. P. Hay Nonpeptide Endothelin Receptor Antagonists. VIII: Attenuation of Acute Hypoxia-Induced Pulmonary Hypertension in the Dog J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 695 - 701. [Abstract] [Full Text]

				C.-J. Kim, M. Bassiouny, R. L. Macdonald, B. Weir, L. M. Johns, and J. E. Brayden Effect of BQ-123 and Tissue Plasminogen Activator on Vasospasm After Subarachnoid Hemorrhage in Monkeys Stroke, September 1, 1996; 27(9): 1629 - 1633. [Abstract] [Full Text]

				O. Valdenaire, E. Rohrbacher, and M.-G.èv. Mattei Organization of the Gene Encoding the Human Endothelin-converting Enzyme (ECE-1) J. Biol. Chem., December 15, 1995; 270(50): 29794 - 29798. [Abstract] [Full Text] [PDF]

				E. R. Levin Endothelins N. Engl. J. Med., August 10, 1995; 333(6): 356 - 363. [Full Text] [PDF]

				T. Kitazono, D. D. Heistad, and F. M. Faraci Enhanced Responses of the Basilar Artery to Activation of Endothelin-B Receptors in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, April 1, 1995; 25(4): 490 - 494. [Abstract] [Full Text]